Breast Cancer Clinical Trial
Official title:
Facilitating Adjustment in Low Income Black Women With Breast Cancer
| Verified date | October 2015 |
| Source | University of Miami |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The main goal of the proposed study is to test whether a successful stress management
intervention can be effectively implemented in natural settings in the community and will be
acceptable to a community dwelling, low income population of African American women with
breast cancer.
Hypothesis 1: There will be no differences between women randomized to either the Cognitive
Behavioral Stress Management (CBSM) or the Cancer Wellness and Education condition (CW) on
ratings of acceptability of the program.
Hypothesis 2: Women randomized to the CBSM condition will show greater decreases over time
in cancer-specific distress and greater increases over time in quality of life as compared
to women in the CW condition over the course of the study from baseline to six month
follow-up.
Hypothesis 3: Women randomized to the CBSM condition will show greater improvement in pain
levels, sleep disturbance and fatigue as compared to women in the CW condition over the
course of the study from baseline to six month follow-up.
Hypothesis 4: Women randomized to the CBSM condition will report fewer sick days, earlier
return to work, fewer unanticipated health care visits, fewer visits to the Emergency
Department and better follow-up with oncologists as compared to women in the CW condition
over the course of the study from baseline to six month follow-up.
Hypothesis 5: Women randomized to the CBSM condition will show more normalized patterns of
diurnal cortisol (e.g., greater increase in negative AM-PM slope) as compared to women in
the CW condition over the course of the study from baseline to six month follow-up.
Hypothesis 6: Women randomized to the CBSM condition will show more less normalized patterns
of heart rate variability (e.g., more variation) as compared to women in the CW condition
over the course of the study from baseline to six month follow-up.
| Status | Completed |
| Enrollment | 114 |
| Est. completion date | May 2015 |
| Est. primary completion date | May 2015 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: - Women who self-identify as Black; - No prior history of cancer; - Age 21 or older; - Life expectancy of >= 12 months; - No history of prior inpatient psychiatric treatment for severe mental illness within 1 year (e.g., psychosis) - No active suicidality; - No substance dependence within the past year; - Fluent in English; - Available for follow-up over the course of the study; - Endorse moderate stress or distress as measured by a score of 4 or above on the a distress thermometer and an adapted thermometer of stress; - Completed treatment for breast cancer (except hormonal therapies) within 12 months. Exclusion Criteria: - Women who do not self-identify as Black; - Prior history of cancer (other than skin cancer); - Under age 21; - A life expectancy of less than 12 months; - History of prior inpatient psychiatric treatment for severe mental illness within the past year (e.g., psychosis), - Active suicidality; - Substance dependence within the past year; - Low English fluency; - Not available for follow-up over the course of the study; - Score below 4 on a distress thermometer and an adapted thermometer of stress; - Are not within 12 months of completing treatment for breast cancer (except hormonal therapies) at the time of recruitment; - Males will be excluded. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| United States | Jackson Health System | Miami | Florida |
| United States | University of Miami | Miami | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| University of Miami | National Cancer Institute (NCI) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Acceptability ratings of the program | Acceptability is measured using a participant self-report scale that was created specifically for this project. This 16-item questionnaire assesses perceived satisfaction with the program, perceived comprehension of the material, comfort with group sessions, perceived competence of the interventionist, satisfaction with project staff, and ratings of project materials on a 4-point Likert scale (completely agree-completely disagree). | 12 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |